RA CAPITAL MANAGEMENT, L.P. - Director, 10%+ Owner at Tyra Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
TYRA on Nasdaq
All Insider Reports
All Insider Reports

RA CAPITAL MANAGEMENT, L.P. - trading volume in the past year for Tyra Biosciences, Inc.

Holdings reported by RA CAPITAL MANAGEMENT, L.P. for Tyra Biosciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10,259,291 $103,926,617 $10.13 16 Jun 2025 Indirect
Pre-Funded Warrants (Right to Buy) 1,000,000 $13,009,000 $13.01 18 Oct 2024 Indirect Common Stock
Stock Option (Right to Buy) 22,200 29 May 2025 Indirect Common Stock

Transactions reported by RA CAPITAL MANAGEMENT, L.P. for Tyra Biosciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.